Elanco Animal Health (ELAN) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Elanco Animal Health (ELAN) do?
Elanco Animal Health Inc (ELAN) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Manufactures medicines, vaccines, and parasite prevention treatments for companion animals and production livestock. The company develops and manufactures prescription pharmaceuticals and parasiticides for pets and farm livestock. It is worth $13.14B on the market and sold $5.15B over the last year.
- Market cap
- $13.14B
- P/E ratio
- None (reported a loss)
- Annual sales
- $5.15B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Brief updated
- Nov 16, 2026
Brands and businesses behind ELAN
- Seresto: Provides long-lasting flea and tick prevention collars for dogs and cats through retail stores and veterinary clinics.
- Credelio: Protects dogs and cats from fleas and ticks using monthly chewable tablets prescribed by veterinarians.
- Zenrelia: Controls canine allergic itch and atopic dermatitis through daily oral tablets sold to veterinary practices.
- Galliprant: Relieves canine osteoarthritis pain and stiffness with daily prescription tablets sold through veterinary clinics.
- Advantage: Delivers topical flea prevention treatments for dogs and cats sold through retail pet channels and clinics.
- Rumensin: Increases feed efficiency and controls disease in commercial cattle herds through medicated feed additives.
ELAN’s flags, in plain English
Each flag is a number from Elanco Animal Health’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.
Stupid Cash
Can pay this year's bills 2.1 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 56% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Wide Gross Margin
Gross margin of 45.3% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.
Burning Cash
Losing money, profit margin of -2.9%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
Questions about ELAN
How big is Elanco Animal Health?
Elanco Animal Health’s market cap is $13.14B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $5.15B: what customers paid the company over the last year, before any costs.
What is ELAN’s P/E ratio?
ELAN has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with ELAN?
High debt levels from past acquisitions restrict operational flexibility and increase ongoing interest expenses. That is one risk on Elanco Animal Health’s card. Its first risk flag is Burning Cash, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Elanco Animal Health’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. ELAN’s filings on SEC.gov. The Margin Monkey is research, not advice.
